Keywords: amylin, losses, widen, spiralling, costs, usa, pharmaceuticals

Amylin's losses widen on spiralling R&D costs

Article | 03 March 2003

Print This

The USA's Amylin Pharmaceuticals has reported a sharp increase in netloss for the fourth quarter and full year ended December 31, 2002, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in